Business Wire

Media-Telecom Convergence Projects Demo by IBC and TM Forum at Digital Transformation World

Share

TM Forum, the industry association driving digital transformation through collaboration, and IBC, the world’s most influential media, entertainment and technology show, unveiled the details of three joint proof-of-concept Catalyst projects to be demonstrated at Digital Transformation World in Nice, France, May 14-16, 2019.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190513005442/en/

Catalysts are proof-of-concept projects developed collaboratively. These projects bring together companies large and small to create innovate solutions to common challenges demonstrating how this can be achieved leveraging key TM Forum best practices and standards.

These three unique Media-Telecom Convergence Catalyst projects are the first results of IBC and TM Forum’s collaboration aimed at driving open innovation between the telecoms and media industries. Featured among the 32 projects demonstrated at Digital Transformation World, they incorporate some of today’s most complex business and technology challenges today, including 5G, data management, virtual and augmented reality, edge computing, AI and the automation of business processes for regulatory compliance.

The three Media-Telecom Catalysts are:

  • 5G-Enabled Tourism Experience
    This Catalyst explores ways of creating a pop-up network for delivery of high throughput broadcasting to distant points of fiber presence via mmWave connection. The project investigates how to deliver rich and engaging video-based experiences to users exploring an area of the Roman Baths in the UK and allows a mobile device to view a place as it would have been in the past. Champions: Aardman Entertainment, BBC R&D Participants: Bristol University, Cambridge Communications Systems Ltd., Zeetta Networks Ltd.
  • AI Indexing for Regulatory Practice
    This Catalyst is exploring ways to intelligently automate the identification of on-air content using AI in order to measure and report against compliance metrics set by external regulatory bodies, as well as for accurate measurement of internal editorial, creative and technical standards. Champions: Associated Press, Al Jazeera, RTE; Participants: Metaliquid, QCRI, Tech Mahindra, V-Nova
  • Mobile News Gathering Using AI-Powered Compression
    This Catalyst is working to empower newsrooms and journalists through improved intelligence for the mobile reporter in the field and faster time-to-air for both live and pre-recorded content. It leverages AI and techniques for improved bandwidth utilization through advanced compression techniques. Champions: Associated Press, Al Jazeera, RTE; Participant: V-Nova

“The convergence between telecom and media and entertainment has opened up exciting opportunities for our members to work alongside some of the world’s leading media companies to solve pressing business challenges,” said Andy Tiller, Executive Vice President, Collaboration and Innovation, TM Forum. “These three projects truly showcase how the power of collaboration helped find unique real-world solutions to problems faced by both industries – not only transforming businesses but consumer experience as well."

“As the pace of technology disruption and convergence accelerates, the rapid-fire Media-Telco Catalyst model for cross-sector innovation, partnerships and broader digital transformation is already proving a game-changing approach.” said Imran Sroya, Director, IBC. “We are delighted with the progress of the first three Catalyst projects and look forward to showcasing them at Digital Transformation World this month and at IBC in Amsterdam in September.”

Learn more about TM Forum’s Catalyst program at Digital Transformation World in Nice, France, May 14-16, 2019. With a focus on intelligent operations for a 5G world, Digital Transformation World showcases how businesses can seize opportunity and remain competitive in a rapidly evolving digital world. Click here for the latest event agenda: https://dtw.tmforum.org/agenda/

Ends

About TM Forum

TM Forum is an association of over 850-member companies’ customers across 180 countries. We drive collaboration and collective problem-solving to maximize the business success of communication and digital service providers and their ecosystem of suppliers around the world. Today, our focus is on supporting members as they navigate their unique digital transformation journeys, providing practical and proven assets and tools to accelerate execution and platforms to facilitate collaborative problem solving and innovation. Learn more at www.tmforum.org.

About IBC

IBC is the world’s most influential media, entertainment and technology show, attracting 55,000+ attendees from more than 170 countries and combining a highly respected and peer-reviewed conference with an exhibition that showcases 1,700+ leading industry suppliers of state-of-the-art technology. In addition to the world-class exhibition and conference, IBC also encompasses the IBC Daily, IBCTV and IBC365.

IBC365 provides year-round insight and opinion into the hot topics and key trends from leading industry journalists, along with insightful whitepapers, peer reviewed technical papers, highly engaging webinars and an expansive video library.

Contact information

CCgroup PR
Anais Merlin
E: TMForum@ccgrouppr.com
T: +44 203 824 9200

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

SHINE Creates Therapeutics Division, Will Attend 2019 European Association of Nuclear Medicine Conference12.10.2019 04:00:00 CESTPress release

SHINE Medical Technologies, LLC today announced the creation of a new division of the company — SHINE Therapeutics. The establishment of the division enhances the company’s ability to focus on filling critical future needs in the rapidly growing therapeutic isotope market, while continuing to leverage its radioisotope production expertise. The company’s Therapeutics division will initially focus on the development and commercialization of lutetium‑177, or Lu‑177, a therapeutic isotope that is combined with a disease-specific targeting molecule to treat cancer. Targeting molecules deliver Lu‑177 atoms to cancer sites throughout the body, where they directly irradiate cancer cells. The first Lu‑177-based targeted radiotherapy (for neuroendocrine tumors) reached the market in 2018. Many high-potential targeted molecules for the treatment of a range of other cancers with Lu-177 are currently under investigation. SHINE is also evaluating additional medical isotopes with therapeutic properti

Smart Taxation – A Step Towards a Fair, Efficient and Growth-Friendly European Taxation Approach11.10.2019 22:01:00 CESTPress release

In a rapidly changing global economy, smart taxation is essential to drive growth and economic prosperity. However, the European Union (EU) continues to fall behind as it persists with a one-size-fits all taxation system. This year’s GLOBSEC Tatra Summit hosts a Focus Group, bringing together international experts, looking to reshape and support a smarter European tax policy. Europe is at a crossroads in adapting its tax policy to the realities of today’s global economy. The EU plays a key role in overseeing national tax rules in some areas - particularly in relation to EU business and consumer policies. The institutional changeover marks a perfect opportunity for the Tatra Summit to place major topics on the radar of decision-makers and offer efficient recommendations. So now is the time to adapt the EU’s taxation model to be fit-for-purpose. With member states around the table, European fiscal authorities should design a model that does not have a disruptive impact on national needs

Clovis Oncology Announces Rubraca®▼ (rucaparib) Now Available for Women with Relapsed Ovarian Cancer in England Through the Cancer Drugs Fund11.10.2019 13:19:00 CESTPress release

Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that the National Institute for Health and Care Excellence (NICE) has recommended that women with relapsed ovarian cancer in England have access to rucaparib through the Cancer Drugs Fund (CDF).1 Rucaparib is available for use within the CDF as an option for the maintenance treatment of relapsed, platinum-sensitive high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer that has responded to platinum-based chemotherapy in adults, based on the conditions outlined in the managed access agreement. "Ovacome welcomes the availability of rucaparib via the CDF as an option for maintenance treatment of platinum-sensitive relapsed high grade serous epithelial ovarian cancer regardless of BRCA status or line of treatment in the relapsed maintenance setting,” said Victoria Clare, CEO of Ovacome, a United Kingdom ovarian cancer charity focused on providing support to anyone affected by ovarian cancer. “It is vital that the exp

Yokogawa Releases Dynamic Real Time Optimizer, a New Solution in the OpreX Asset Operations and Optimization Family11.10.2019 02:00:00 CESTPress release

Yokogawa Electric Corporation (TOKYO:6841) announces the release of Dynamic Real Time Optimizer, a solution in the OpreXTM Asset Operations and Optimization family. Using a combination of first principles simulation and multivariable predictive control technology, the Dynamic Real Time Optimizer software helps to optimize plant operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191010005009/en/ Operating window of Dynamic Real Time Optimizer (Graphic: Yokogawa Electric Corporation) This integrated solution is based on Yokogawa’s advanced process control technologies and industry knowledge and simulation technologies developed by KBC Advanced Technologies Limited (KBC, CEO: Andrew Howell), a UK-based Yokogawa subsidiary. This solution enables plants to quickly respond to dynamically changing oil market and product market conditions and improve both productivity and profitability. Development Background Advanced proces

Gilead and Galapagos Announce Efficacy and Safety Results of Filgotinib Through 52 Weeks in FINCH 1 and FINCH 3 Studies in Rheumatoid Arthritis10.10.2019 22:00:00 CESTPress release

Gilead Sciences, Inc. (NASDAQ: GILD) and Galapagos NV (Euronext & NASDAQ: GLPG) today announced that Week 52 data from the registrational Phase 3 FINCH 1 and FINCH 3 trials of filgotinib, an investigational, oral, selective JAK1 inhibitor, for the treatment of moderately-to-severely active rheumatoid arthritis (RA) are consistent with and support the efficacy, safety and tolerability profiles demonstrated in the Week 12 and 24 analyses presented earlier this year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191010005875/en/ “We are encouraged by the durability of both the efficacy and safety profiles of filgotinib seen in these studies,” said John Sundy, MD, PhD, Senior Vice President, Inflammation and Respiratory Diseases, Gilead Sciences. “These data suggest that filgotinib if approved, may play an important role in helping people living with rheumatoid arthritis achieve sustained, clinically meaningful responses.” “The

Gilead Sciences to Release Third Quarter 2019 Financial Results on Thursday, October 24, 201910.10.2019 20:05:00 CESTPress release

Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its third quarter 2019 financial results will be released on Thursday, October 24, after the market closes. At 4:30 p.m. Eastern Time, Gilead’s management will host a conference call to discuss the company’s financial results for the third quarter 2019 and provide a business update. The live webcast of the call can be accessed at the company’s Investors page at http://investors.gilead.com/. Please connect to the company’s website at least 15 minutes prior to the start of the call to ensure adequate time for any software download that may be required to listen to the webcast. Alternatively, please call 877-359-9508 (U.S.) or 224-357-2393 (international) and dial the conference ID 6094972 to access the call. Telephone replay will be available approximately two hours after the call through 8:00 p.m. Eastern Time, October 26, 2019. To access the replay, please call 855-859-2056 (U.S.) or 404-537-3406 (international) and dial the con